RP11
Showing 1 - 25 of 4,413
Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)
Recruiting
- Retinal Dystrophy
- +2 more
-
Dallas, TexasRetina Foundation of the Southwest
Jun 5, 2023
Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic
Recruiting
- Borderline Resectable Pancreatic Carcinoma
- +8 more
- Capecitabine
- +7 more
-
Portland, OregonOHSU Knight Cancer Institute
Aug 25, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)
Active, not recruiting
- Malignant Supratentorial Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting
- Retinitis Pigmentosa
- +4 more
-
San Francisco, California
- +4 more
Oct 5, 2022
Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Cytarabine
- +4 more
-
Brewer, Maine
- +8 more
Jun 18, 2021
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Trial in Rochester (drug, radiation, other, biological, procedure)
Completed
- Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
- Docetaxel
- +5 more
-
Rochester, MinnesotaMayo Clinic
Mar 16, 2020
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,
Active, not recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +5 more
- Biopsy
- +7 more
-
Lewes, Delaware
- +42 more
Mar 15, 2022
Danon Disease Trial in La Jolla, Philadelphia (RP-A501)
Recruiting
- Danon Disease
- RP-A501
-
La Jolla, California
- +1 more
Oct 17, 2023
Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
-
Fairfax, VirginiaNEXT Oncology
Jun 7, 2023
Triple Negative Breast Tumors Trial in Worldwide (Atezolizumab, Placebo, Gemcitabine)
Recruiting
- Triple Negative Breast Neoplasms
- Atezolizumab
- +4 more
-
Fort Myers, Florida
- +165 more
Jan 12, 2023
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)
Not yet recruiting
- Locally Advanced Unresectable Pancreatic Adenocarcinoma
- Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
- (no location specified)
Jun 25, 2023
Deep Brain Stimulation, Parkinson Disease Trial in Shanghai (remote programming, standard programming)
Not yet recruiting
- Deep Brain Stimulation
- Parkinson Disease
- remote programming
- standard programming
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 8, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Dexamethasone Associated With Axillary Plexus on Occurrence of
Not yet recruiting
- Adjuvants, Anesthesia
- Brachial Plexus Anesthesia
- upper extremity bone surgery
- (no location specified)
Mar 8, 2023